Replicate Bioscience is amplifying the power of RNA therapeutics by pioneering novel self-replicating RNA (srRNA) technology. Replicate’s off-the-shelf srRNAs contain two components: virally derived genetic code to drive controlled and self-limiting amplification, and the RNA encoding therapeutic proteins. Our library of viral vectors, selected for driving robust and sustained protein expression and orders-of-magnitude improved performance over linear mRNA, allow for the development of treatments in applications including oncology, infectious disease, and autoimmunity.
Differentiated by a team of srRNA experts, a customizable library of synthetic srRNA vectors, and end-to-end development capabilities, Replicate is uniquely positioned to finally expand the reach of RNA treatments toward widespread use in infectious disease, immuno-oncology, autoimmune disease, and more.
Company Details
- Employees
- 21
- Founded
- -
- Address
- 10210 Campus Point Dr,
- in****@****nce.com
- Industry
- Biotechnology
- Website
- replicatebioscience.com
- Keywords
- Manager jobs.
- HQ
- San Diego, California
Replicate Bioscience, Inc. Questions
Replicate Bioscience, Inc.'s website is replicatebioscience.com
Replicate Bioscience, Inc.'s LinkedIn profile is https://www.linkedin.com/company/replicate-bioscience-inc
Replicate Bioscience, Inc. has
21 employees.
View email and phone details for 21
employees at Replicate Bioscience, Inc..
Replicate Bioscience, Inc.'s industry is
Biotechnology
Replicate Bioscience, Inc.'s top competitors are
Ascidian Therapeutics,
Replay,
Capricor Therapeutics, Inc.,
Arcturus Therapeutics,
Atamyo Therapeutics,
Orbital Therapeutics,
Crinetics Pharmaceuticals,
Alliance For Mrna Medicines,
Andelyn Biosciences,
Aulos Bioscience.
Replicate Bioscience, Inc.'s support email address is info@replicatebioscience.com
Replicate Bioscience, Inc.'s categories are Biotechnology
Replicate Bioscience, Inc.'s founding year is 2020
